MN1 alteration characterizes a recently described group of neuroepithelial tumors with varied morphological features. In cIMPACT-NOW update 6, only those with astroblastoma morphology has been accepted as a newly recognized tumor type, whereas the rest of morphological variants are considered lesions sub-judice. We perform an individual patient data meta-analysis of MN1-altered neuroepithelial tumors comprising a total of 73 cases, in order to study the survival data and predictive markers for better diagnosis and management of this rare molecular entity. The 5- and 10-year progression-free survival are 38% and 0%, whereas the 5- and 10-year overall survival are 89% and 55%, respectively. Among all the morphological variants of MN1-altered tumor, astroblastoma morphology is significantly associated with an improved overall survival, emphasizing the importance of providing an integrated histologic and molecular diagnosis. Histological grading within the molecularly-defined MN1-altered astroblastoma remains controversial. In tumors with astroblastoma morphology, the odds of MN1-altered status among patients less than 15-year-old is 10.5 times that of those 15-year-old and older, and female of 9.4 times that of the male gender. Gross tumor resection appears as main treatment modality for better disease control based on observational data.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Boisseau W, Euskirchen P, Mokhtari K, Dehais C, Touat M, Hoang-Xuan K et al (2019) Molecular profiling reclassifies adult astroblastoma into known and clinically distinct tumor entities with frequent mitogen-activated protein kinase pathway alterations. Oncologist 24:1584–1592. https://doi.org/10.1634/theoncologist.2019-0223
Brat D, Perry A (2018) Other glial neoplasms. In: Brat D, Perry A (eds) Practical surgical neuropathology a diagnostic approach, 2nd edn. Elsevier, Philadelphia, pp 175–178
Burford A, Mackay A, Popov S, Vinci M, Carvalho D, Clarke M et al (2018) The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion. Neuro-Oncology 20:i40. https://doi.org/10.1093/neuonc/noy059
Hirose T, Nobusawa S, Sugiyama K, Amatya VJ, Fujimoto N, Sasaki A et al (2018) Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement. Brain Pathol 28:684–694. https://doi.org/10.1111/bpa.12565
Korshunov A, McLendon R, Judkins A, Pfister S, Eberhart C, Fuller G et al (2016) Embryonal tumour with multilayered rosettes, C19MC-altered In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system revised, 4th edn. International Agency for Research on Cancer, Lyon, pp 201–205
Lehman NL, Hattab EM, Mobley BC, Usubalieva A, Schniederjan MJ, McLendon RE et al (2017) Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. Neuro Oncol 19:31–42. https://doi.org/10.1093/neuonc/now118
Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC et al (2019) Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun 7:42. https://doi.org/10.1186/s40478-019-0689-3
Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A et al (2014) International Society of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435. https://doi.org/10.1111/bpa.12171
Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. https://doi.org/10.1111/bpa.12832
McLendon R, Judkins A, Eberhart C, Fuller G, Sarkar C, Ng H et al (2016) Other CNS embryonal tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system revised, 4th edn. International Agency for Research on Cancer, Lyon, pp 206–208
Mhatre R, Sugur HS, Nandeesh BN, Chickabasaviah Y, Saini J, Santosh V (2019) MN1 rearrangement in astroblastoma: study of eight cases and review of literature. Brain Tumor Pathol 36:112–120. https://doi.org/10.1007/s10014-019-00346-x
Neumann JE, Spohn M, Obrecht D, Mynarek M, Thomas C, Hasselblatt M et al (2019) Molecular characterization of histopathological ependymoma variants. Acta Neuropathol. https://doi.org/10.1007/s00401-019-02090-0
Otero JJ, Rowitch D, Vandenberg S (2011) OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol 104:423–438. https://doi.org/10.1007/s11060-010-0509-x
Petruzzellis G, Alessi I, Colafati GS, Diomedi-Camassei F, Ciolfi A, Pedace L et al (2019) Role of DNA methylation profile in diagnosing astroblastoma: a case report and literature review. Front Genet 10:391. https://doi.org/10.3389/fgene.2019.00391
Shin SA, Ahn B, Kim SK, Kang HJ, Nobusawa S, Komori T et al (2018) Brainstem astroblastoma with MN1 translocation. Neuropathology 38:631–637. https://doi.org/10.1111/neup.12514
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072. https://doi.org/10.1016/j.cell.2016.01.015
Svajdler M, Rychly B, Mezencev R, Frohlichova L, Bednarova A, Pataky F et al (2016) SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: an immunohistochemical study of 98 glial tumors. Histol Histopathol 31:95–102. https://doi.org/10.14670/HH-11-654
Wood MD, Tihan T, Perry A, Chacko G, Turner C, Pu C et al (2018) Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Brain Pathol 28:192–202. https://doi.org/10.1111/bpa.12561
Yamada SM, Tomita Y, Shibui S, Takahashi M, Kawamoto M, Nobusawa S et al (2018) Primary spinal cord astroblastoma: case report. J Neurosurg Spine 28:642–646. https://doi.org/10.3171/2017.9.SPINE161302
Conflict of interest
The authors declare that they have no financial or conflict of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Chen, W., Soon, Y.Y., Pratiseyo, P.D. et al. Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases. Brain Tumor Pathol (2020). https://doi.org/10.1007/s10014-020-00372-0
- Primitive neuroepithelial tumor
- CNS HGNET-MN1